Thursday 3 July 2014
INDIAN
EQUITY BENCHMARKS ended with marginal losses, amid a lacklustre trading
session, as investors booked profits after the sharp rally yesterday which saw
the Sensex and Nifty hitting fresh record highs. The losses were led by oil and
gas shares.
Further,
Ranbaxy Laboratories has gained 3.8%, its highest level since November 2012
after after USFDA granted approval to Ranbaxy's subsidiary Ohm Laboratories to
manufacture and sell generic Diovan in the US. Sesa Sterlite
closed 2% higher after the company was permitted to resume production in the
Goa state in September.
The
crucial resistance for Nifty is now seen at 7755 and above this 7785.
Support for the immediate term is now placed at 7675 and next
support will be 7620.
For 2 Days Free Trial, please
visit our site at www.capitalstars.com or Call at
0731-6790000
